{"ATC Code":"N05CD02","Abbreviation":"","Aliases":["Benzalin","Mogadon","Neozepam","Imeson","Remnos","Eunoctin","Neuchlonic","Nitrados","Radedorm","Trazenin"],"Biological Half-Life":"15-38 hours (mean elimination half life 26 hours).","CAS":"146-22-5","ChEBI":"CHEBI:7581","ChEMBL":"CHEMBL13209","ChemicalClasses":["benzodiazepine"],"Chirality":"achiral","Classes":null,"DEA no":2834,"Drug Classes":"Breast Feeding; Lactation; Milk, Human; Hypnotics and Sedatives; Anti-Anxiety Agents; Benzodiazepines","Drug Indication":"Used to treat short-term sleeping problems (insomnia), such as difficulty falling asleep, frequent awakenings during the night, and early-morning awakening.","DrugClasses":[],"EINECS":"205-665-2","EliminationHalfLife":"16 – 38 hours","European Community (EC) Number":"205-665-2","HMDB ID":"HMDB0015534","HeavyAtomCount":21,"Human Drugs":"Breast Feeding; Lactation; Milk, Human; Hypnotics and Sedatives; Anti-Anxiety Agents; Benzodiazepines","IUPACName":"7-nitro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one","InChI":"InChI=1S/C15H11N3O3/c19-14-9-16-15(10-4-2-1-3-5-10)12-8-11(18(20)21)6-7-13(12)17-14/h1-8H,9H2,(H,17,19)","InChIKey":"KJONHKAYOJNZEC-UHFFFAOYSA-N","MeSH Pharmacological Classification":"Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)","Melting Point":"225 °C","MolecularFormula":"C\u003csub\u003e15\u003c/sub\u003eH\u003csub\u003e11\u003c/sub\u003eN\u003csub\u003e3\u003c/sub\u003eO\u003csub\u003e3\u003c/sub\u003e","MolecularWeight":"281.27 g/mol","Pharmacodynamics":"Nitrazepam is a type of benzodiazepine drug. It is a powerful hypnotic drug which possesses strong sedative, anxiolytic, amnestic, anticonvulsant, and skeletal muscle relaxant properties. Nitrazepam shortens the time required to fall asleep and lengthens the duration of sleep. It is also useful for the management of myoclonic seizures.","Physical Description":"Solid","PrevSalts":[],"PubChemId":4506,"Record Description":["Nitrazepam is a 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one which is substituted at positions 5 and 7 by phenyl and nitro groups, respectively. It is used as a hypnotic for the short-term management of insomnia and for the treatment of epileptic spasms in infants (West's syndrome). It has a role as an anticonvulsant, an antispasmodic drug, a GABA modulator, a sedative and a drug metabolite. It is a 1,4-benzodiazepinone and a C-nitro compound.","Nitrazepam is a DEA Schedule IV controlled substance. Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III. It is a Depressants substance.","A benzodiazepine derivative used as an anticonvulsant and hypnotic.","Nitrazepam has been reported in Apis cerana with data available.","NITRAZEPAM is a small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 6 investigational indications.","Nitrazepam is only found in individuals that have used or taken this drug. It is a benzodiazepine derivative used as an anticonvulsant and hypnotic. Nitrazepam belongs to a group of medicines called benzodiazepines. It acts on benzodiazepine receptors in the brain which are associated with the GABA receptors causing an enhanced binding of GABA (gamma amino butyric acid) to GABAA receptors. GABA is a major inhibitory neurotransmitter in the brain, involved in inducing sleepiness, muscular relaxation and control of anxiety and fits, and slows down the central nervous system. The anticonvulsant properties of nitrazepam and other benzodiazepines may be in part or entirely due to binding to voltage-dependent sodium channels rather than benzodiazepine receptors. Sustained repetitive firing seems to be limited by benzodiazepines effect of slowing recovery of sodium channels from inactivation.","A benzodiazepine derivative used as an anticonvulsant and hypnotic.","Nitrazepam is a 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one which is substituted at positions 5 and 7 by phenyl and nitro groups, respectively. It is used as a hypnotic for the short-term management of insomnia and for the treatment of epileptic spasms in infants (West's syndrome). It has a role as an anticonvulsant, an antispasmodic drug, a GABA modulator, a sedative and a drug metabolite. It is a 1,4-benzodiazepinone and a C-nitro compound."],"RefCount":4,"References":[{"Name":"Wikipedia","Urls":[{"Link":"https://en.wikipedia.org/wiki/Nitrazepam","Name":"Nitrazepam","Sub":false}]},{"Name":"Wikidata","Urls":[{"Link":"https://www.wikidata.org/wiki/Q410078","Name":"Nitrazepam","Sub":false}]},{"Name":"DrugBank","Urls":[{"Link":"https://go.drugbank.com/drugs/DB01595","Name":"Nitrazepam","Sub":false}]},{"Name":"PubChem","Urls":[{"Link":"https://pubchem.ncbi.nlm.nih.gov/compound/4506","Name":"Nitrazepam","Sub":false}]},{"Name":"ChEMBL","Urls":[{"Link":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL13209","Name":"Nitrazepam","Sub":false}]},{"Name":"ChEBI","Urls":[{"Link":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:7581","Name":"Nitrazepam","Sub":false}]},{"Name":"Common Chemistry","Urls":[{"Link":"https://commonchemistry.cas.org/detail?cas_rn=146-22-5","Name":"Nitrazepam","Sub":false}]},{"Name":"HMDB","Urls":[{"Link":"https://hmdb.ca/metabolites/HMDB0015534","Name":"Nitrazepam","Sub":false}]},{"Name":"KEGG","Urls":[{"Link":"https://www.kegg.jp/entry/C07487","Name":"Nitrazepam","Sub":false}]},{"Name":"UNII","Urls":[{"Link":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/9CLV70W7HS","Name":"Nitrazepam","Sub":false}]},{"Name":"EPA DSSTox","Urls":[{"Link":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID5023372","Name":"Nitrazepam","Sub":false}]}],"Refs":["National Center for Biotechnology Information. PubChem Compound Summary for CID 4506, Nitrazepam. Accessed July 3, 2025. \u003ca href=https://pubchem.ncbi.nlm.nih.gov/compound/4506\u003ehttps://pubchem.ncbi.nlm.nih.gov/compound/4506\u003c/a\u003e","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Nitrazepam. UNII: 9CLV70W7HS. Global Substance Registration System. Accessed July 3, 2025. \u003ca href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/9CLV70W7HS\u003ehttps://gsrs.ncats.nih.gov/ginas/app/beta/substances/9CLV70W7HS\u003c/a\u003e","Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. March 31, 2023. Accessed July 3, 2025. \u003ca href=https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992\u003ehttps://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992\u003c/a\u003e"],"SMILES":"C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3","Scheduling":[{"gov":"Brazil","ref":["3"],"schedule":"B1 substance"},{"gov":"Canada","ref":[],"schedule":"Schedule IV substance"},{"gov":"Australia","ref":[],"schedule":"Schedule 4 substance"},{"gov":"Germany","ref":[],"schedule":"prescription only/Anlage III substance"},{"gov":"United Nations","ref":[],"schedule":"Schedule IV substance"}],"Solubility":"\u003e42.2 [ug/mL] (The mean of the results at pH 7.4)","StoreUNII":["9CLV70W7HS"],"StructureBase64":"<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" height="91.494mm" version="1.2" viewBox="0 0 94.7 91.494" width="94.7mm">
      
    <desc>Generated by the Chemistry Development Kit (http://github.com/cdk)</desc>
      
    <g fill="#3050F8" stroke="#000000" stroke-linecap="round" stroke-linejoin="round" stroke-width=".7">
            
        <rect fill="#FFFFFF" height="92.0" stroke="none" width="95.0" x=".0" y=".0"/>
            
        <g class="mol" id="mol1">
                  
            <line class="bond" id="mol1bnd1" x1="88.956" x2="82.352" y1="28.691" y2="14.975"/>
                  
            <g class="bond" id="mol1bnd2">
                        
                <line x1="81.036" x2="88.456" y1="14.668" y2="5.406"/>
                        
                <line x1="82.939" x2="90.359" y1="16.193" y2="6.931"/>
                      
                <line class="hi" stroke="#FF0D0D" x1="88.456" x2="84.74600000000001" y1="5.405999999999999" y2="10.036999999999999"/>
                <line class="hi" stroke="#FF0D0D" x1="90.359" x2="86.649" y1="6.931000000000001" y2="11.562000000000001"/>
            </g>
                  
            <line class="bond" id="mol1bnd3" x1="82.352" x2="70.823" y1="14.975" y2="12.29"/>
                  
            <line class="bond" id="mol1bnd4" x1="64.487" x2="55.632" y1="13.957" y2="21.071"/>
                  
            <g class="bond" id="mol1bnd5">
                        
                <line x1="55.632" x2="55.632" y1="36.311" y2="21.071"/>
                        
                <line x1="53.193" x2="53.193" y1="34.903" y2="22.479"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd6" x1="55.632" x2="42.424" y1="36.311" y2="43.931"/>
                  
            <g class="bond" id="mol1bnd7">
                        
                <line x1="29.216" x2="42.424" y1="36.311" y2="43.931"/>
                        
                <line x1="31.654" x2="42.424" y1="34.903" y2="41.116"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd8" x1="29.216" x2="29.216" y1="36.311" y2="21.071"/>
                  
            <g class="bond" id="mol1bnd9">
                        
                <line x1="42.424" x2="29.216" y1="13.451" y2="21.071"/>
                        
                <line x1="42.424" x2="31.654" y1="16.266" y2="22.479"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd10" x1="55.632" x2="42.424" y1="21.071" y2="13.451"/>
                  
            <line class="bond" id="mol1bnd11" x1="29.216" x2="21.666" y1="36.311" y2="40.671"/>
                  
            <g class="bond" id="mol1bnd12">
                        
                <line x1="12.256" x2="5.486" y1="43.169" y2="39.262"/>
                        
                <line x1="13.475" x2="6.705" y1="41.057" y2="37.15"/>
                      
                <line class="hi" stroke="#3050F8" x1="12.256" x2="8.871" y1="43.169" y2="41.2155"/>
                <line class="hi" stroke="#3050F8" x1="12.256" x2="8.871" y1="43.169" y2="41.2155"/>
                <line class="hi" stroke="#FF0D0D" x1="5.486" x2="8.871" y1="39.262" y2="41.2155"/>
                <line class="hi" stroke="#3050F8" x1="13.475" x2="10.09" y1="41.057" y2="39.1035"/>
                <line class="hi" stroke="#3050F8" x1="13.475" x2="10.09" y1="41.057" y2="39.1035"/>
                <line class="hi" stroke="#FF0D0D" x1="6.705" x2="10.09" y1="37.15" y2="39.1035"/>
            </g>
                  
            <line class="bond" id="mol1bnd13" x1="16.019" x2="16.02" y1="47.783" y2="55.221"/>
                  
            <line class="bond" id="mol1bnd14" x1="55.632" x2="67.519" y1="36.311" y2="45.861"/>
                  
            <g class="bond" id="mol1bnd15">
                        
                <line x1="67.519" x2="79.048" y1="45.861" y2="43.176"/>
                        
                <line x1="68.121" x2="78.495" y1="43.217" y2="40.802"/>
                      
                <line class="hi" stroke="#3050F8" x1="79.048" x2="73.2835" y1="43.176" y2="44.5185"/>
                <line class="hi" stroke="#3050F8" x1="78.495" x2="73.30799999999999" y1="40.802" y2="42.0095"/>
            </g>
                  
            <line class="bond" id="mol1bnd16" x1="88.956" x2="84.139" y1="28.691" y2="38.696"/>
                  
            <line class="bond" id="mol1bnd17" x1="67.519" x2="64.133" y1="45.861" y2="60.721"/>
                  
            <g class="bond" id="mol1bnd18">
                        
                <line x1="75.319" x2="64.133" y1="71.084" y2="60.721"/>
                        
                <line x1="72.628" x2="63.508" y1="71.916" y2="63.465"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd19" x1="75.319" x2="71.933" y1="71.084" y2="85.943"/>
                  
            <g class="bond" id="mol1bnd20">
                        
                <line x1="57.362" x2="71.933" y1="90.439" y2="85.943"/>
                        
                <line x1="57.988" x2="69.869" y1="87.694" y2="84.029"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd21" x1="57.362" x2="46.177" y1="90.439" y2="80.075"/>
                  
            <g class="bond" id="mol1bnd22">
                        
                <line x1="49.563" x2="46.177" y1="65.216" y2="80.075"/>
                        
                <line x1="51.627" x2="48.868" y1="67.131" y2="79.244"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd23" x1="64.133" x2="49.563" y1="60.721" y2="65.216"/>
                  
            <path class="atom" d="M94.14 3.078q.0 .756 -.256 1.328q-.256 .565 -.756 .881q-.5 .315 -1.244 .315q-.756 .0 -1.262 -.315q-.506 -.316 -.756 -.887q-.244 -.572 -.244 -1.334q-.0 -.75 .244 -1.309q.25 -.566 .756 -.881q.506 -.316 1.274 -.316q.732 .0 1.232 .316q.5 .309 .756 .875q.256 .565 .256 1.327zM90.277 3.078q-.0 .923 .387 1.459q.393 .53 1.22 .53q.839 -.0 1.22 -.53q.387 -.536 .387 -1.459q.0 -.929 -.387 -1.452q-.381 -.524 -1.208 -.524q-.833 -.0 -1.226 .524q-.393 .523 -.393 1.452z" fill="#FF0D0D" id="mol1atm3" stroke="none"/>
                  
            <g class="atom" id="mol1atm4">
                        
                <path d="M69.46 13.97h-.721l-2.619 -4.066h-.03q.012 .238 .03 .596q.024 .357 .024 .732v2.738h-.566v-4.899h.715l2.607 4.054h.03q-.006 -.107 -.018 -.327q-.012 -.221 -.024 -.477q-.006 -.262 -.006 -.482v-2.768h.578v4.899z" stroke="none"/>
                        
                <path d="M69.323 8.509h-.619v-2.286h-2.513v2.286h-.613v-4.899h.613v2.071h2.513v-2.071h.619v4.899z" stroke="none"/>
                      
            </g>
                  
            <g class="atom" id="mol1atm11">
                        
                <path d="M17.959 46.383h-.72l-2.619 -4.066h-.03q.012 .238 .03 .595q.023 .357 .023 .732v2.739h-.565v-4.9h.714l2.608 4.054h.03q-.006 -.107 -.018 -.327q-.012 -.22 -.024 -.476q-.006 -.262 -.006 -.482v-2.769h.577v4.9z" stroke="none"/>
                        
                <path d="M19.635 41.339h.818v.293h-.818v.846h-.296v-.846h-.818v-.293h.818v-.85h.296v.85z" stroke="none"/>
                      
            </g>
                  
            <path class="atom" d="M5.078 36.312q.0 .756 -.256 1.328q-.256 .565 -.756 .881q-.5 .315 -1.244 .315q-.756 .0 -1.262 -.315q-.506 -.316 -.756 -.887q-.244 -.572 -.244 -1.334q.0 -.75 .244 -1.309q.25 -.566 .756 -.881q.506 -.316 1.274 -.316q.732 .0 1.232 .316q.5 .309 .756 .875q.256 .565 .256 1.327zM1.215 36.312q-.0 .923 .387 1.459q.393 .53 1.22 .53q.84 -.0 1.221 -.53q.387 -.536 .387 -1.459q-.0 -.928 -.387 -1.452q-.381 -.524 -1.209 -.524q-.833 -.0 -1.226 .524q-.393 .524 -.393 1.452z" fill="#FF0D0D" id="mol1atm12" stroke="none"/>
                  
            <g class="atom" id="mol1atm13">
                        
                <path d="M18.28 59.17q.0 .756 -.256 1.328q-.256 .565 -.756 .881q-.5 .315 -1.244 .315q-.756 .0 -1.262 -.315q-.506 -.316 -.756 -.887q-.244 -.572 -.244 -1.334q-.0 -.75 .244 -1.309q.25 -.566 .756 -.882q.506 -.315 1.274 -.315q.732 -.0 1.232 .315q.5 .31 .756 .876q.256 .565 .256 1.327zM14.417 59.17q-.0 .923 .387 1.459q.393 .529 1.22 .529q.839 .0 1.22 -.529q.387 -.536 .387 -1.459q.0 -.929 -.387 -1.452q-.381 -.524 -1.208 -.524q-.833 -.0 -1.226 .524q-.393 .523 -.393 1.452z" fill="#FF0D0D" stroke="none"/>
                        
                <path d="M20.774 56.505v.293h-1.932v-.293h1.932z" fill="#FF0D0D" stroke="none"/>
                      
            </g>
                  
            <path class="atom" d="M84.293 44.857h-.72l-2.62 -4.066h-.029q.012 .238 .029 .595q.024 .357 .024 .732v2.739h-.565v-4.9h.714l2.608 4.054h.029q-.006 -.107 -.018 -.327q-.011 -.22 -.023 -.476q-.006 -.262 -.006 -.483v-2.768h.577v4.9z" id="mol1atm15" stroke="none"/>
                
            <line class="hi" id="mol1bnd3" stroke="#3050F8" x1="70.823" x2="76.5875" y1="12.29" y2="13.6325"/>
            <line class="hi" id="mol1bnd3" stroke="#3050F8" x1="70.823" x2="76.5875" y1="12.29" y2="13.6325"/>
            <line class="hi" id="mol1bnd4" stroke="#3050F8" x1="64.487" x2="60.0595" y1="13.957" y2="17.514000000000003"/>
            <line class="hi" id="mol1bnd4" stroke="#3050F8" x1="64.487" x2="60.0595" y1="13.957" y2="17.514000000000003"/>
            <line class="hi" id="mol1bnd11" stroke="#3050F8" x1="21.666" x2="25.441000000000003" y1="40.671" y2="38.491"/>
            <line class="hi" id="mol1bnd11" stroke="#3050F8" x1="21.666" x2="25.441000000000003" y1="40.671" y2="38.491"/>
            <line class="hi" id="mol1bnd13" stroke="#3050F8" x1="16.019" x2="16.0195" y1="47.783" y2="51.501999999999995"/>
            <line class="hi" id="mol1bnd13" stroke="#3050F8" x1="16.019" x2="16.0195" y1="47.783" y2="51.501999999999995"/>
            <line class="hi" id="mol1bnd13" stroke="#FF0D0D" x1="16.02" x2="16.0195" y1="55.221" y2="51.501999999999995"/>
            <line class="hi" id="mol1bnd13" stroke="#FF0D0D" x1="16.02" x2="16.0195" y1="55.221" y2="51.501999999999995"/>
            <line class="hi" id="mol1bnd16" stroke="#3050F8" x1="84.139" x2="86.5475" y1="38.696" y2="33.6935"/>
        </g>
          
    </g>
    
</svg>
","Subjective Effects":null,"Title":"Nitrazepam","UNII":"9CLV70W7HS","Wikidata":"Q410078","Wikipedia":"Nitrazepam","XLogP":2.2}
